1)  factor Ⅴ Leiden mutation
凝血第因子Leiden突变
2)  coagulation
凝血
1.
Observation of Coagulation-anticoagulation and Fibrinolytic System Function in Abnormal Humour Syndrome Patients with Coronary Heart Disease;
异常体液型冠心病患者凝血、抗凝和纤溶系统功能的变化
2.
Changes and significance of coagulation,anticoagulation,fibrinolysis in elderly hypertensive patients complicated with cerebral infarction;
老年高血压并发脑梗死患者凝血、抗凝、纤溶系统功能改变及意义
3.
The effect of the low-dose recombinant factor Ⅶa on coagulation parameters of patients undergoing liver transplantation;
小剂量重组凝血因子Ⅶa对肝移植凝血功能的影响
3)  blood coagulation
凝血
1.
Relationship between dysfunction of blood coagulation and endothelial cell injury in obstructive jaundice;
梗阻性黄疸凝血障碍与血管内皮细胞损伤的关系
2.
The Clinical Significance Of Blood Coagulation Ang Platelet Measurement for Patients with Acute Severe Hepatitis;
急性重型肝炎患者凝血及血小板测定的临床意义
3.
The effects of estrogen and laser irradiation on platelet aggregation and blood coagulation;
雌激素与激光照射对血小板聚集和凝血的作用
4)  clotting
凝血
1.
Compared with uncoated NiTi, 316L stainless steel and Ti6Al4V, TiO_2-coated NiTi exhibits excellent hemocompatibility, such as lower hemolysis rate and longer clotting time.
结果表明:在NiTi表面形成金红石型TiO2薄膜;覆盖有TiO2薄膜的NiTi合金与NiTi基体及316L不锈钢、Ti6Al4V相比,凝血时间延长,溶血率下降,说明TiO2膜可提高NiTi合金血液相容性。
2.
Objective: To study the changes of clotting and fibrinolysis in patients with chronic atrial fibrillation complicated by cerebral infarction.
目的:了解慢性心房纤颤(房颤)并发脑梗死患者的凝血、纤溶功能状态。
5)  thrombin-antithrombinⅢ
凝血酶-抗凝血酶Ⅲ
6)  coagulant material
凝血材料
1.
A kind of coagulant material composed of hyaluronic acid-type I collagen-chitosan(HCC) was prepared,and the morphological properties of this HCC complex film were characterized.
将制备的新型凝血材料——透明质酸-Ⅰ型胶原-壳聚糖(HA-COL-CS,简称HCC)复合膜与血小板作用,发现能加强血小板的粘附与聚集,血小板形态发生很大变化,并首次在血小板表面发现颗粒状物质的释放。
参考词条
补充资料：凝血第Ⅷ因子
药物名称：冻干人抗血友病球蛋白

英文名：

别名： 冻干人抗血友病球蛋白;冷沉淀物;凝血第Ⅷ因子
适应症：
本品适用于防治血友病甲（先日性凝血因子Ⅷ缺乏症）、获得性凝血因子Ⅷ缺乏症和血管性假血友病的补充疗法。对血友病乙（缺乏凝血因子Ⅸ）无效。
用量用法：
静滴：通常每次５～１０Ｕ／ｋｇ，用２５～３０℃的注射用水１００ｍｌ溶解，于２０分钟内输完。每隔１２～２４小时１次，连用３～５日即可。在出血量较大或大手术时，剂量可加大２～３倍，间隔时间可缩短，滴速６０滴／分钟，输液器应有滤网装置。
注意事项： 大剂量输注（每日超过２０Ｕ／ｋｇ）时可出现肺水肿。本制品应与受血者ＡＢＯ血型相同。
规格： 针剂：２００Ｕ（相当于２００ｍｌ血浆中所含的ＡＨＧ），另含纤维蛋白原０．１～０．２ｇ。


类别：促凝血药
说明：补充资料仅用于学习参考，请勿用于其它任何用途。